A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

MLA

Masaru Konishi, et al. “A Randomized Phase III Trial of Adjuvant S-1 Therapy vs. Observation Alone in Resected Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).” Japanese Journal of Clinical Oncology, vol. 48, Feb. 2018, pp. 392–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99d67e16be9eee70291ea48261a9391f&authtype=sso&custid=ns315887.

APA

Masaru Konishi, Kohei Nakachi, Takuji Okusaka, Junko Eba, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse, Junki Mizusawa, Hepatobiliary, & Masafumi Ikeda. (2018). A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT). Japanese Journal of Clinical Oncology, 48, 392–395.

Chicago

Masaru Konishi, Kohei Nakachi, Takuji Okusaka, Junko Eba, Hiroshi Ishii, Haruhiko Fukuda, Junji Furuse, Junki Mizusawa, Hepatobiliary, and Masafumi Ikeda. 2018. “A Randomized Phase III Trial of Adjuvant S-1 Therapy vs. Observation Alone in Resected Biliary Tract Cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT).” Japanese Journal of Clinical Oncology 48 (February): 392–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....99d67e16be9eee70291ea48261a9391f&authtype=sso&custid=ns315887.